Generali Investments CEE’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Sell
25,766
-618
-2% -$56.4K 0.11% 196
2026
Q1
$2.71M Sell
26,384
-2,049
-7% -$231K 0.14% 181
2025
Q4
$3.56M Hold
28,433
– – 0.25% 135
2025
Q3
$3.81M Buy
28,433
+375
+1% +$49.2K 0.29% 108
2025
Q2
$3.82M Buy
28,058
+800
+3% +$105K 0.31% 106
2025
Q1
$3.62M Sell
27,258
-992
-4% -$126K 0.34% 100
2024
Q4
$3.2M Buy
+28,250
New +$3.26M 0.33% 100

Other funds holding ABT

Generali Investments CEE's ABT Position: Q2 2026 in Review

Generali Investments CEE reduced its Abbott (ABT) stake by 2.3% in Q2 2026, selling an estimated $56.4K and leaving 25,766 shares worth $2.34M. The position accounts for 0.11% of the portfolio, ranked #196.

Generali Investments CEE first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.82M in Q2 2025. 2,982 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Generali Investments CEE held 25,766 shares of Abbott worth $2.34M as of Q2 2026.
  • Generali Investments CEE sold 618 Abbott shares in Q2 2026, an estimated $56.4K.
  • Abbott made up 0.11% of Generali Investments CEE's portfolio in Q2 2026, its #196 holding.
  • Generali Investments CEE first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Abbott position peaked at $3.82M in Q2 2025.
  • 2,982 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.